PRostate Olaparib Real World Evidence Study
Recruiting now
Conditions studied: Metastatic Castration-resistant Prostate Cancer
In brief
This French non-interventional longitudinal multicenter cohort study is conducted to study the added value of olaparib in the treatment of patients with mCRPC in the real world setting in terms of treatment sequencing, effectiveness, safety and BRCA testing patterns and thus inform future clinical practice.
Key facts
- Study ID
- NCT06031805
- Run by
- AstraZeneca
- People needed
- 300
- Starts
- 2023-10-11
- Expected to finish
- 2028-10-13
- Last updated by the study team
- 2026-06-02
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may not qualify if…
- Patients opposed to the collection of their data
- Patients participating in a clinical trial with an investigational prostate cancer targeted drug within 30 days prior to Olaparib initiation
Where it is running
- Research Site — Mantes-la-Jolie, France (enrolling)
- Research Site — ORL ANS, France (enrolling)
- Research Site — Le Coudray, France (enrolling)
- Research Site — Lyon, France (enrolling)
- Research Site — Nantes, France (enrolling)
- Research Site — Nice, France (enrolling)
- Research Site — Amiens, France (enrolling)
- Research Site — Bordeaux, France (enrolling)
- Research Site — Levallois-Perret, France (enrolling)
- Research Site — Challes-les-Eaux, France (enrolling)
- Research Site — Nancy, France (enrolling)
- Research Site — Antony, France (enrolling)
- Research Site — Besançon, France (enrolling)
- Research Site — Clermont-Ferrand, France (enrolling)
- Research Site — Argenteuil, France (enrolling)
- Research Site — Compiègne, France (enrolling)
- Research Site — Créteil, France (enrolling)
- Research Site — Epagny METZ Tessy, France (enrolling)
- Research Site — Avignon, France (enrolling)
- Research Site — Ermont, France (enrolling)
- Research Site — FORT de France, France (enrolling)
- Research Site — Fréjus, France (enrolling)
- Research Site — Chambray-lès-Tours, France (enrolling)
- Research Site — Grenoble, France (enrolling)
- Research Site — Paris, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.